Clinical presentation and outcome in a cohort of paediatric patients with membranous lupus nephritis

Nephrology Dialysis Transplantation

Volumn 22, Issue 12, 2007, Pages 3495-3500

  Cramer II, Carl H ^a   Mills, Michelle ^b   Valentini, Rudolph P ^c   Smoyer, William E ^b   Haftel, Hillary ^b   Brophy, Patrick D ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Membranous nephropathy; Paediatrics; Systemic lupus erythematosus

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEMENT BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DISEASE CLASSIFICATION; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FUNCTION TEST; KIDNEY GRAFT REJECTION; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION;

ADOLESCENT; BIOPSY; CHILD; FEMALE; HUMANS; LUPUS NEPHRITIS; MALE; RETROSPECTIVE STUDIES;

EID: 36749039840     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm491     Document Type: Article

References (20)

1. Southwest Pediatric Nephrology Study Group. Comparison of idiopathic and SLE-associated membranous glomerulopathy in children. Am J Kidney Dis 1986; 7: 115-124
2. Sorof JM, Perez MD, Brewer ED, Hawkins EP, Warren RW. Increasing incidence of childhood class V lupus nephritis. J Rheumatol 1998; 25: 1413-1418
3. Cameron J. Lupus nephritis in childhood and adolescence. Pediatr Nephrol 1994; 8: 230-249
4. Baqi N, Moazami S, Singh A, Ahmad H, Balachandra S, Tejani A. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J Am Soc Nephrol 1996; 7: 924-929
5. Yang LY, Chen WP, Lin CY. Lupus nephritis in children - a review of 167 patients. Pediatrics 1994; 94: 335-340
6. McCurdy DK, Lehman TJA, Berstein B et al. Lupus nephritis: prognostic factors in children. Pediatrics 1992; 89: 240-246
7. Hagelberg S, Lee Y, Bargman J et al. Long term follow up of childhood lupus nephritis. J Rheumatol 2002; 29: 2635-2642
8. Nathanson S, Salomon R, Ranchin B et al. Prognosis of lupus membranous nephropathy in children. Pediatr Nephrol 2006; 21: 1113-1116
9. Sloan RP, Schwartz MM, Korbet SM, Borok RZ. Lupus Nephritis Collaborative Study Group: long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. J Am Soc Nephrol 1996; 7: 299-305
10. Radhakrishnan J, Kunis CL, Agati VD, Appel GB. Cyclosporine treatment of lupus membranous nephropathy. Clin Nephrol 1994; 42: 147-154
11. Moroni G, Maccario M, Banfi G, Quaglini S, Ponticelli C. Treatment of membranous lupus nephritis. Am J Kidney Dis 1998; 31: 681-686
12. Pasquali S, Banfi G, Zucchelli A, Moroni G, Ponticelli C, Zucchelli P. Lupus membranous nephropathy: long-term outcome. Clin Nephrol 1993; 39: 175-182
13. Baldwin DS, Gluck MC, Lowenstein J, Gallo GR. Lupus nephritis. Clinical course as related to morphological forms and their transition. Am J Med 1977; 62: 12-30
14. Donadio JV,Jr, Hart GM, Bergstralh EJ, Holley KE. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus 1995; 4: 109-115
15. Boumpas DT, Austin HA,3rd, Vaughn EM et al. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992; 340: 741-745
16. Najafi CC, Korbert SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J for the Lupus Nephritis Collaborative Study Group. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerluonephritis. Kidney Int 2001; 59: 2156-2163
17. Mercadal L, Tezenas du Montcel S, Nochy D, Queffeulou G, Piette JC, Isnard-Bagnis C, Martinez F and the Groupe d'Etudes Nephroloqiques en Ile de France. Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant 2002; 17: 1771-1778
18. Moroni G, Pasquali S, Quaglini S et al. Clinical and prognostic value of serial renal biopsies in lupus nephritis. Am J Kidney Dis 1999; 34: 530-539
19. Troyanov S, Wall CA, Miller JA, Scholey JW, Cattran DC for the Toronto Glomerulonephritis Registry Group. Idiopathic membranous nephropathy: definition and relevance of partial remission. Kidney Int 2004; 66: 1199-1205
20. Spetie DN, Tang Y, Rovin BH et al. Mycophenolate therapy of SLE membranous nephropathy. Kidney Int 2004; 66: 2411-2415